Atom Grants
Discover
  • Dashboard
  • Search
  • Deep Research
  • Favorites
  • Projects

    SBIR/STTR Commercialization Readiness Pilot (CRP) Program (Parent SB1 Clinical Trial Optional)

    NIH supports small businesses moving funded research toward commercialization through later-stage development, clinical studies, manufacturing scale-up, and specialized technical assistance.

    OverviewSimilar Grants
    OverviewSimilar Grants

    Funder: National Institutes of Health

    Due Dates: January 5, 2027 (Application) | April 5, 2027 (Application) | September 5, 2027 (Application) | January 5, 2028 (Application) | April 5, 2028 (Application) | September 5, 2028 (Application) | January 5, 2029 (Application) | April 5, 2029 (Application)

    Funding Amounts: Component guidelines of $500,000, $2,000,000, or the SBA CRP limit; maximum 3 years; no cost sharing

    Summary: Supports late-stage development and technical assistance to move NIH-funded SBIR/STTR technologies toward commercialization.

    Key Information: Only U.S. small businesses with qualifying NIH Phase II or Phase IIB funding within the last 36 months may apply; one CRP award per project.


    Description

    The NIH Commercialization Readiness Pilot (CRP) program provides additional support to small businesses advancing NIH-funded SBIR or STTR projects toward commercialization. It funds later-stage research and development, technical assistance, or both, including activities not typically supported by Phase II or Phase IIB Strategic Breakthrough awards. Projects must align with a participating NIH Institute, Center, or Office’s mission.

    Supported work includes independent confirmation of key studies, IND- or IDE-enabling studies, clinical studies, manufacturing development and scale-up, quality systems activities, regulatory strategy, intellectual property strategy, and market research. Businesses may outsource a significant portion of the work while retaining substantive scientific, programmatic, financial, and administrative oversight. Clinical trials are optional, but several participating components do not accept them through this opportunity.


    Atom

    See the full grant listing

    Sign in to view full eligibility details, sources, similar grants, and AI-powered analysis.